SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) shares fell 1.2% on Tuesday. The stock traded as low as $24.38 and last traded at $24.38. 200 shares were traded during mid-day trading, a decline of 88% from the average session volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Price Performance
The stock has a market cap of $6.64 billion, a PE ratio of 48.76, a P/E/G ratio of 1.30 and a beta of 1.81. The firm’s 50 day moving average price is $24.38 and its two-hundred day moving average price is $24.38.
About SWEDISH ORPHAN/S
Swedish Orphan Biovitrum AB, commonly known as Sobi, is a Sweden-based biopharmaceutical company focused on developing and providing treatments for rare diseases. The company’s activities primarily cover hematology, immunology, and other conditions in which patients have limited treatment options.
Sobi’s portfolio includes therapies for bleeding disorders, immune-mediated diseases, and rare inflammatory conditions. Its products and services span the development, manufacturing, commercialization, and distribution of medicines, with the company also working with external partners to bring specialized treatments to patients.
Headquartered in Stockholm, Sobi serves patients and healthcare providers internationally through operations and commercial partnerships across Europe, North America, and other markets.
Further Reading
- Five stocks we like better than SWEDISH ORPHAN/S
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
